Pharmaceutical company Glenmark's Finacea, generic skin care drug, that was under patent litigation, violates patent of Bayer. The US District Court of Delaware at Wilmington, has said that claims of Bayer Healthcare Pharmaceuticals Inc, Intendis and ... Med India, 2 months ago
US court rejects Glenmark's patent plea for Finacea - Business Standard, 2 months ago
Jaguar Animal Health Signs Crofelemer Manufacturing & Supply Agreement With Glenmark Pharmaceuticals Ltd.
Jaguar Animal Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, announced today that it has ...TheStreet.com, 1 week ago
Shares of Glenmark Pharmaceuticals rose 5.9 per cent intraday to mark its record high as it received final approval from the the United States Food & Drug Administration. (Reuters) Shares of Glenmark Pharmaceuticals rose 5.9 per cent intraday to ...Financial Express, 1 month ago Glenmark receives USFDA nod for oral contraceptive drug Financial Express, 1 month ago Glenmark Pharma gets ANDA approval for drospirenone and ethinyl estradiol tablets Money Control, 1 month ago Glenmark at record high on USFDA nod for oral contraceptive MSN News US, 1 month ago
Cipla stocks will be in focus today as the the Indian generic drugmaker on Friday informed BSE that its UK arm, Cipla EU, has entered into definitive agreements to acquire two US-based companies InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals ...Financial Express, 1 month ago Sensex, Nifty drop more than 2% ahead of US payrolls data Livemint.com, 1 month ago Sensex closes 563 points down, lowest in nearly 14 months; Nifty ends at 7,655 Financial Express, 1 month ago
Glenmark Pharmaceuticals on Thursday posted 3.29 per cent rise in consolidated net profit at Rs 190.93 crore for the first quarter ended June 30, driven by sales in domestic as well as overseas markets. The Mumbai-based company had posted a net profit of Rs ...The Financial Chronicle, 2 months ago
A team from Ropes & Gray that included IP litigation partner Sona De helped Bayer Healthcare Pharmaceuticals Inc. notch a win in its patent suit A team from Ropes & Gray that included IP litigation partner Sona De helped Bayer Healthcare ...Inside Counsel, 2 weeks ago
Posted by Equitymaster After facing losses in the early hours of the trade, the Indian Markets reversed direction and have rushed into the green. Sectoral indices are trading on a mixed note with stocks from the pharma and software sectors leading the gains.Equitymaster.com, 1 month ago
Benchmark Indices ended lower for the fourth consecutive session on concerns of capital outflows after the special investigation team proposed stringent norms for P-notes. Further, investors turned catious ahead of the US Federal Open Market Committee (FOMC) meeting that begins today, which could further give signals on whether the Fed will hike the rates. The BSE Sensex ended 102 points or 0.3% down at 27,459 while the CNX Nifty ended below 8,350 at 8,337 levels, down by 24 points or 0.3%. The ...Rediff.com, 2 months ago
on your WebpageAdd Widget >Get your members hooked!